Podcasts about Health policy

About this episode: From working in immigrant health care under the Reagan administration to tackling today's measles outbreak in Florida, George Rust has decades of experience caring for the disadvantaged. In this episode: Dr. Rust discusses the state of public health in Florida, the need to return to a community-focused model, and his new book "Healing in a Changing America: Doctoring in a Nation of Needless Suffering." Guest: Dr. George Rust, PhD, is a family physician, a preventative public health specialist, and a professor at the Florida State University School of Medicine. Host: Dr. Josh Sharfstein is distinguished professor of the practice in Health Policy and Management, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: Healing in a Changing America: Doctoring in a Nation of Needless Suffering—Johns Hopkins University Press (book) Concerning outbreak of measles reported in SW Florida—FOX 35 Orlando Florida Removes Over Quarter of People From Health Care Plan—Newsweek Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌PublicHealthPod on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

This time on Code WACK! We're taking a closer look at what happens when private equity buys hospitals. Our guest is Dr. Renee Hsia (pronounced “Shaw”). An emergency physician at Zuckerberg San Francisco General Hospital, Dr. Hsia explains how patients can be harmed when Wall Street firms take over health care. A Professor of Emergency Medicine and Health Policy at the University of California, San Francisco, she is also Vice Chair of Health Services Research in the Department of Emergency Medicine, and a core faculty member of the Philip R. Lee Institute for Health Policy Studies. This is part two of our two-part series. Check out the Transcript and Show Notes for more! Keep Code WACK! on the air with a tax-deductible donation.

This time on Code WACK! We're taking a closer look at what happens when private equity buys hospitals. Our guest is Dr. Renee Hsia (pronounced "Shaw"). An emergency physician at Zuckerberg San Francisco General Hospital, Dr. Hsia explains how patients can be harmed when Wall Street firms take over health care. A Professor of Emergency Medicine and Health Policy at the University of California, San Francisco, she is also Vice Chair of Health Services Research in the Department of Emergency Medicine, and a core faculty member of the Philip R. Lee Institute for Health Policy Studies. This is part two of our two-part series. Check out the Transcript and Show Notes for more!  Keep Code WACK! on the air with a tax-deductible donation.   

For people living with kidney disease, clinical trials can offer hope—but not without questions or concerns. Today, we talk with Dr. Nadine Barrett, Glenda Roberts, and Luz Baqueiro about lived experience, community trust, and the power of being asked. In this episode we heard from:  Dr. Nadine J. Barrett is a Professor in the Department of Social Sciences and Health Policy in the Division of Public Health Sciences and the inaugural Senior Associate Dean of Community Engagement and Equity in Research at Wake Forest School of Medicine, she is Associate Director of Community Outreach and Engagement for Wake Forest Comprehensive Cancer Center, the Clinical Translational Science Institute and the Maya Angelou Center for Health Equity. Prior to joining Wake Forest, Dr. Barrett served 13 years in senior leadership roles at Duke University, as the Founding Director of both the Duke Center for Equity in Research and the nationally awarded, Duke Cancer Institute's Office of Health Equity. She is also President of the national Association of Cancer Care Centers, in Washington DC. A medical sociologist by training, Dr. Barrett is a health disparities researcher, expert equity strategist, and a nationally recognized leader in facilitating authentic community, healthcare, and academic partnerships to advance health equity. She develops multi-level interventions to address implicit bias, structural and systemic racism, and inequities that limit access to quality research and trustworthy health care among underserved and marginalized populations. Dr. Barrett brings an equity lens to her work and collaborations to enhance healthcare systems, close the disparities gap in health outcomes, and increase diverse and broad representation in research participation and the research workforce. Glenda Roberts: Prior to joining the Mount Sinai Center for Kidney Disease Innovation as the Director of Communications and Patient Engagement, Glenda V. Roberts was an Information Technology executive with over 35 years of experience with top-caliber corporations, including General Electric, Microsoft and Johnson & Johnson. She was also the Executive Director of the Seattle Transplant House, and the Director of External Relations & Patient Engagement at the University of Washington Center for Dialysis Innovation (CDI) and the Kidney Research Institute (KRI). Before going on dialysis, Glenda managed the progression of her disease for over 40 years using diet and exercise. Since her transplant in 2010, she's completed nine half marathons. Based upon her personal experience with kidney disease, Glenda is a passionate activist for kidney research and patients living with kidney disease. She's involved in myriad patient-centered national and international health care transformation initiatives.  All are focused on addressing patient preferences and improving patient-reported outcomes.   Glenda brings the patient voice to several NIH/NIDDK government and industry research efforts (Kidney Precision Medicine Project, APOLLO), as well as the American Society of Nephrology's Current & Emerging Threats (C-ET) Steering Committee. She's the inaugural co-chair of the Critical Path Institute's Biomarker Data Repository Governance Committee, and a member of the Kidney Health Initiative (KHI) Board of Directors. Additionally, she contributes to the Advisory Boards of LifeCenter Northwest and Home Dialyzors United, and over 15 other industry and academic research advisory committees/boards focused on transplantation, kidney, cardiovascular, and metabolic health. As an ambassador for the National Kidney Foundation, the American Kidney Fund, and the American Association of Kidney Patients, Glenda's advocacy tirelessly advances the voices, needs, and aspirations of the kidney community worldwide. Luz Baqueiro serves as a patient advocate with the National Kidney Foundation (NKF), providing feedback and helping develop new initiatives to better support the Latin American community affected by chronic kidney disease. She also raises awareness of the barriers faced by patients living with renal failure while educating and supporting her community in Georgia. In 2019, Luz was diagnosed with end-stage renal disease (ESRD). With limited resources  in Georgia, she relied on emergency in-hospital dialysis for a year. In August 2021, through self-determination, self-education, and the support of her family and community, she received a kidney transplant.   Additional Resources Clinical Trial Information Hub What is a Clinical Trial? Are Clinical Trials Safe?   Do you have comments, questions, or suggestions? Email us at NKFpodcast@kidney.org. Also, make sure to rate and review us wherever you listen to podcasts.

Health Affairs' Jeff Byers welcomes Deputy Editor Leslie Erdelack back to the pod to break down recent turbulence at the FDA following the departure of Vinay Prasad, whose decisions around rare‑disease gene therapies courted controversy. They explore the fast‑growing rare disease therapeutics market, why traditional clinical trials often don't work for ultra‑rare genetic conditions, and the new FDA draft guidance for rare disease drug development. On March 24th, join us for our upcoming Insider exclusive event focusing on pharmacy benefit manager reform with Harvard Medical School's Benjamin Rome.Become an Insider to get access to this event, trend reports, cheat sheets, and exclusive newsletters.Related Articles:FDA vaccines chief who ran afoul of pharma to depart (Politico)Rare Disease Therapeutics Market to Surpass US$ 495.27 Billion by 2033 as Gene Therapy, RNA-based Drugs, and Biologics Transform Patient Care (PR Newswire)FDA NEWS RELEASE: FDA Launches Framework for Accelerating Development of Individualized Therapies for Ultra-Rare Diseases FDA illuminates new approval pathway for bespoke gene editing therapies (Fierce Biotech)One Pivotal Trial, the New Default Option for FDA Approval — Ending the Two-Trial Dogma (The New England Journal of Medicine)

Epidemiologist Yvonne “Bonnie” Maldonado is an expert in vaccine research and public health. Look back centuries, and the story is always the same, she says: Death rates from viruses have plummeted, especially in children and the elderly. And yet, millions of children die each year from vaccine-preventable diseases. Vaccines need a return of public confidence, and that starts with better messaging and greater support of nongovernmental messengers like herself. The bottom line is that vaccines are safe, she says. Vaccines work and we have saved many lives because of them, Maldonado reminds host Russ Altman on this episode of Stanford Engineering's The Future of Everything podcast. Have a question for Russ? Send it our way in writing or via voice memo, and it might be featured on an upcoming episode. Please introduce yourself, let us know where you're listening from, and share your question. You can send questions to thefutureofeverything@stanford.edu. Episode Reference Links: Stanford Profile: Yvonne Maldonado Connect With Us: Episode Transcripts >>> The Future of Everything Website Connect with Russ >>> Threads / Bluesky / Mastodon Connect with School of Engineering >>> Twitter/X / Instagram / LinkedIn / Facebook Chapters: (00:00:00) Introduction Russ Altman introduces guest Yvonne “Bonnie” Maldonado, a professor of pediatrics, epidemiology and population health at Stanford University. (00:03:01) Career in Vaccines Bonnie shares what led to her career in vaccine research. (00:04:53) How Vaccines Work How vaccines train the immune system to recognize and fight pathogens. (00:06:46) Why Vaccine Responses Vary The variability in immune responses and breakthrough infections. (00:09:22) Risk vs. Benefit in Vaccines How researchers evaluate side effects versus disease severity. (00:11:53) How Viruses Evolve The evolutionary dynamics that shape viral behavior. (00:13:59) Vaccine Boosters Why some vaccines last for life while others require multiple doses. (00:17:14) Herd Immunity How community protection works and why vaccination rates matter. (00:21:22) Vaccine Controversy The controversy surrounding vaccines and what led to it. (00:24:27) Global Vaccine Hesitancy How declining trust and past outbreaks influence vaccination globally. (00:27:07) The Future of Vaccines Why vaccines are essential and how outbreaks shape public response. (00:29:08) Preparing for Future Pandemics How healthcare systems prepare for new threats after COVID-19. (00:30:43) Future In a Minute Rapid-fire Q&A: hope, public trust, and the future of health. (00:32:54) Conclusion Connect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>>Twitter/X / Instagram / LinkedIn / Facebook Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

About this episode: Getting your license as a teenager is an exciting time but it's also a dangerous one. In this episode: Johns Hopkins researcher Johnathon Ehsani discusses why teens are more vulnerable to serious crashes, how driving tests and licensing laws can improve safety, and how parents can best support their new drivers. Please send this podcast to a new driver or their parents—today. Guest: Johnathon Ehsani, PhD, MPH, is an internationally recognized road safety researcher and an associate professor in Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health. Host: Dr. Josh Sharfstein is distinguished professor of the practice in Health Policy and Management, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: Learner Driver Experience and Teenagers' Crash Risk During the First Year of Independent Driving—JAMA Pediatrics What Helps a New Driver? More Driving—New York Times Keeping Teen Drivers Safe—Hopkins Bloomberg Public Health Magazine Carrying Passengers as a Risk Factor for Crashes Fatal to 16- and 17-Year-Old Drivers—JAMA Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌PublicHealthPod on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

In this episode of Home Health Revealed, Hannah Vale sits down with Alex Hartzman, Vice President of Research & Analytics at the National Alliance for Care at Home and Head of Operations at the Research Institute for Home Care, to discuss the policy, payment, and workforce trends shaping the future of home health. They explore the ongoing pressure from Medicare reimbursement changes, the impact of value-based purchasing and quality metrics, and the growing workforce challenges affecting agencies across the country. The conversation also dives into the increasing demand for home-based care, access-to-care concerns, and why the story of home health is not always reaching policymakers the way it should. If you're a home health leader trying to prepare for the years ahead, this episode offers an inside look at the data, policy conversations, and industry realities that will define the future of care at home. Listeners interested in getting involved in advocacy efforts can learn more through the National Alliance for Care at Home Advocacy Action Center and find details about Alliance membership opportunities on their website. The Alliance DC Advocacy Fly-In will take place September 13–16, and Alliance members will receive registration information directly. Chapters (00:00:03) - Home Health Revealed(00:00:25) - Alex Hartzman on Policy Influence in Home Care(00:01:27) - Top 3 issues facing home health agencies(00:05:30) - What Can an Average Home Health Agency Do to Improve Their Quality Score(00:09:37) - Risk of rehospitalization(00:10:35) - Home Health Agency Executives on Staff turnover(00:14:15) - The value of home health(00:19:49) - Home Health and Hospice: A Conversation

About this episode: Dentists prescribe about 10% of all antibiotics in the U.S., but research shows that a large share may be unnecessary. In this episode: the grave public health risks of inappropriate antibiotic use, how this can be curbed, and the questions you should ask next time you're in the dentist's chair. Guest: Liz Szabo, MA, is an investigative health reporter with CIDRAP News. Host: Dr. Josh Sharfstein is distinguished professor of the practice in Health Policy and Management, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: Antibiotic Aftershocks—CIDRAP News Evidence-based clinical practice guideline on antibiotic use for the urgent management of pulpal- and periapical-related dental pain and intraoral swelling—JADA Assessment of the Appropriateness of Antibiotic Prescriptions for Infection Prophylaxis Before Dental Procedures, 2011 to 2015—JAMA A Second, Silent Pandemic: Antibiotic Resistance—Global Health Now Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌PublicHealthPod on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

Abbas Hassan is a plastic surgery resident at the Indiana University School of Medicine. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A.M. Hassan and J.F. Waljee. Valuing Care Provided by Residents and Fellows — Toward Competency-Based Billing. N Engl J Med 2026;394:1041-1043.

This week on Code WACK!, HEAL California's podcast on healthcare justice, we're digging into what happens when private investors buy hospitals and try to make them more profitable — and what that could mean for patient care. Guest: Dr. Renee Hsia (pronounced “Shaw”) — emergency physician at San Francisco General Hospital and Professor of Emergency Medicine and Health Policy at the University of California, San Francisco.

In this episode, Suzanne Spradley and Chase Cannon review the outlook of health policy in the current Washington, DC environment. Suzanne leads off, setting the stage with a description of the narrow House Republican majority and its impact on enacting legislation. Suzanne and Chase discuss several pieces of legislation focused on transparency, including site-neutral payment reform and drug pricing. The two address regulatory activity that potentially targets PBMs and No Surprises Act issues. The episode concludes with a discussion of legislative and regulatory impact on employer group health plans.

Health Affairs' Rob Lott interviews Dr. Ezekiel Emanuel about his new book, Eat Your Ice Cream: Six Simple Rules for a Long and Healthy Life. He explains why he wrote a wellness guide for the general public, what frustrates him about today's “wellness industrial complex,” and why evidence‑based habits — not trendy supplements or extreme routines — are key to long‑term health.Pick up a copy of his new book, Eat Your Ice Cream: Six Simple Rules for a Long and Healthy Life.Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcast

About this episode: The Trump administration's online prescription drug platform promises the world's lowest prices on medications. In this episode: Dr. Mariana Social explains how the site's discounts work, who they benefit, and whether they're truly the most affordable prices. Guest: Dr. Mariana Socal, PhD, MPP, MSc, studies the pharmaceutical market and is an associate professor in Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health. Host: Stephanie Desmon, MA, is a former journalist, author, and the director of public relations and communications for the Johns Hopkins Center for Communication Programs. Show links and related content: Fact Sheet: President Donald J. Trump Launches TrumpRx.gov to Bring Lower Drug Prices to American Patients—The White House TrumpRx launches, but it's unclear if it will lower drug prices for most patients—CNN Tariffs on Pharmaceuticals—Public Health On Call (June 2025) Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌PublicHealthPod on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

This time on Code WACK!  What happens to staff and patients when private investors buy hospitals to make them more profitable? And why should this concern us all? To break it down, we spoke to Dr. Renee Hsia, an attending physician at San Francisco General Hospital and Trauma Center and a Professor of Emergency Medicine and Health Policy at the University of California, San Francisco. She's also Vice Chair of Health Services Research in the Department of Emergency Medicine, and a core faculty member of the Philip R. Lee Institute for Health Policy Studies. This is the first episode in a two-part series. Check out the Transcript and Show Notes for more!  Keep Code WACK! on the air with a tax-deductible donation.   

This time on Code WACK! What happens to staff and patients when private investors buy hospitals to make them more profitable? And why should this concern us all? To break it down, we spoke to Dr. Renee Hsia ( pronounced “Shaw”) an attending physician at San Francisco General Hospital and Trauma Center and a Professor of Emergency Medicine and Health Policy at the University of California, San Francisco. She's also Vice Chair of Health Services Research in the Department of Emergency Medicine, and a core faculty member of the Philip R. Lee Institute for Health Policy Studies. This is the first episode in a two-part series. Check out the Transcript and Show Notes for more! Keep Code WACK! on the air with a tax-deductible donation.

In this episode, Dr. Bill Cooper, Senior Vice President for Professionalism and Clinical Excellence at Vanderbilt University Medical Center and Cornelius Vanderbilt Professor of Pediatrics and Health Policy at Vanderbilt University School of Medicine, shares how structured feedback, credo based evaluations, and peer led cup of coffee conversations strengthen culture and patient safety. He explains how timely, respectful interventions improve clinician behavior, engagement, and overall care delivery.

Health Affairs' Jeff Byers welcomes Senior Editor Margaret Winchester to the pod to discuss Trump's recent State of the Union Address and unpacking its health care and health policy talking points, including most-favored nation drug pricing, health savings accounts, and if there's a path toward codification for either.On March 24th, join us for our upcoming Insider exclusive event focusing on pharmacy benefit manager reform with Harvard Medical School's Benjamin Rome.Related Articles:National Health Care Spending Increased 7.2 Percent In 2024 As Utilization Remained Elevated (Health Affairs)Trump's State of the Union trumpets healthcare greatest hits, but no new policies (Healthcare Dive)

On this episode of Astonishing Healthcare, Lloyd Fiorini, General Counsel & Chief Compliance Officer at Judi Health, returns to the studio for a discussion about the barrage of regulatory changes shaping the pharmacy benefit manager (PBM) landscape in early 2026. Within just two weeks, the Department of Labor announced new proposed rules, the Consolidated Appropriations Act of 2026 became law, and the FTC's announced a settlement with Express Scripts. Then, to top it all off, TrumpRx went live.Lloyd offers clear, helpful explanations of the key takeaways from each of these concurrent reforms aimed at improving transparency and how PBMs operate and interact with the other stakeholders in the supply chain, from independent pharmacies to patients and plan sponsors (employers). Whether you're responsible for a self-funded plan or overseeing a Medicare Part D plan, this episode provides the detail and insights about where the puck is going that you need. As Lloyd said, "I think we've made a great step forward, but the work isn't done."It's also worth giving a shoutout to previous guest Jim Winkler, as "Change is Imminent" is in the title of AH090!Episode HighlightsThe Department of Labor's historic proposed rules on PBM disclosures fills a gap left by the CAA of 2021The Consolidated Appropriations Act of 2026 redefines the financial alignment of pharmacy benefits beyond just Medicare Part Patient/plan member protection seems to be what the FTC's recent settlement was all aboutTrumpRx signals a broader shift toward transparent, cost-plus pricing models, but it's just for cash-paying customers, at least for nowDelinking and efforts to block vertical integration are hotly contestedRelated ContentAH095 - What's in Store for the New Year? A Special Round-Robin Episode of Astonishing HealthcareHow to obtain Rx data and what to do with itAH096 - A Quick Government Programs Update: The IRA & MPPP, Managing D-SNPs, and More, with Jason BarrettoSigns it is time to change your PBM vendor, and how to overcome common hesitationsReference LinksUS Department of Labor proposes historic pharmacy benefit manager fee disclosure rule (January 29)PBM Reforms Signed Into Law, Reshaping Medicare Part D Drug Pricing Transparency (February 3)FTC Secures Landmark Settlement with Express Scripts to Lower Drug Costs for American Patients (February 4)TrumpRx Launches (February 6)For more information about Judi Health and this episode, please visit Judi Health - Insights.

This month is 40 years since host Julie Rovner, chief Washington correspondent for KFF Health News, began reporting on health policy in Washington. To mark the anniversary, Rovner is joined by two longtime sources to discuss what has — and has not — changed since 1986.This week's special guests are Chip Kahn, a former GOP House and Senate staffer and former head of the Federation of American Hospitals and the Health Insurance Association of America, and Chris Jennings, a former Democratic Senate staffer and a health policy adviser to Bill Clinton, Barack Obama, and Joe Biden.Visit our website to read a transcript of this episode.

About this episode: Baby bonds programs, which create state-managed trust funds for low-income children, are associated with positive physical and mental health outcomes for recipients and their families. New research shows that a majority of Americans support these early wealth-building tools. In this episode: Professor Catherine Ettman talks about the growing excitement behind baby bonds and the state models that have already seen success. Note: The CLIMB study mentioned in this episode is supported by the de Beaumont Foundation and the Hopkins Nexus award. Guest: Catherine K. Ettman, PhD, is an assistant professor in Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health, where she studies population mental health and assets. Host: Lindsay Smith Rogers, MA, is the producer of the Public Health On Call podcast, an editor for Expert Insights, and the director of content strategy for the Johns Hopkins Bloomberg School of Public Health. Show links and related content: Majority of U.S. Adults Support Wealth-Building Investments for Children from Low-Income Families—Johns Hopkins Bloomberg School of Public Health CT Baby Bonds—CT.gov The Great Smoky Mountains Study: developmental epidemiology in the southeastern United States—Social Psychiatry and Psych A study in Oklahoma that funded college accounts for newborns is showing promise.—New York Times Trump Accounts—TrumpAccounts.gov Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌PublicHealthPod on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

Ruqaiijah Yearby is a professor at the Temple University Beasley School of Law. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. R. Yearby and M. Alsan. Private Equity's Transformation of American Medicine — Implications for Health Equity. N Engl J Med 2026;394:937-940.

Send a textHow dangerous is loneliness to your health? In this clip from our episode “The Wellness Industry Is Misleading You”, host John Driscoll speaks with Zeke Emanuel about the data linking close friendships to longer life, including research showing significantly higher mortality among those with few close relationships.Listen to the full episode here

The lecture examines the various economic, institutional, and political factors that are driving these approaches to health system reform drawing on work by the Partnership for Health System Sustainability and Resilience (www.phssr.org) of which the LSE is a founding partner, and will consider what these mean for health outcomes. The lecture will also reflect on what these developments can reveal about the future direction of health policy in other parts of the Middle East. Meet our speakers Professor Alistair McGuire is the Kuwait Chair of Health Economics at the Department of Health Policy and at the LSE Middle East Centre. Prior to this he was Professor of Economics at City University, London after being a tutor in Economics at the University of Oxford. Professor McGuire has also been a Visiting Professor at Harvard University, the University of Sydney, the University of York, the Universitat of Barcelona and the Universitat Pompeu Fabra Barcelona. George Wharton is Deputy Head of Department (Teaching) Department of Health Policy, with an academic background in International Relations (BSc, LSE) and Health Policy (MSc, Imperial). George's work focuses on a broad range of themes in comparative international health policy. Meet our chair Katerina Dalacoura is Associate Professor in International Relations at the London School of Economics and Political Science, and Director of the LSE Middle East Centre. She held a Major Research Fellowship by the Leverhulme Trust between 2021 and 2024. The project findings will shortly be published as a book monograph by Cambridge University Press, under the title Islamic International Thought in Turkey: History, Civilisation and Nation.

After a turbulent 2025, the early months of 2026 are proving that the policy landscape isn't quieting down. Federal agencies are rolling out new payment models, lawmakers are revisiting long debated rules, and courts continue to shape what policies move forward and which stall. From value based payment to drug pricing and site of care policy, leaders are navigating a fast shifting environment with real implications for finances, operations, and long term strategy. In this episode, host Abby Burns invites three Advisory Board experts to break down the major policy forces that leaders need to watch now: [1:35] Clare Wirth explains the newest wave of value based payment models out of CMMI, and what they signal about this administration's posture toward value-based care. [10:20] Nick Hula explores how site neutral payments, the return of inpatient only list changes, and state level certificate of need laws could accelerate site of care shifts. [20:51] Chloe Bakst unpacks the chaos surrounding 340B — from the halted rebate pilot to impacts of HR1 and emerging state reporting requirements — and the decisions leaders must make today to prepare for what's coming next. We're here to help: Webinar | How to be successful under TEAM Cheat sheet | 340B Drug Pricing Program Ready-to-Use Resource | Policy Scenario Impact Calculator Expert Insight | How policy changes will impact your bottom line Expert Insight | Inside CMS' final rule changes for 2026 Stay Informed | Healthcare Policy Updates Timeline Radio Advisory's Health Policy playlist Webinar | Join Optum Advisory experts at this upcoming webinar to learn how optimizing patient access unlocks the value of digital innovations and drives long-term sustainability A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

Health Affairs' Rob Lott interviews Derek T. Lake on his recent paper exploring new research on Optum's acquisitions, finding the company tended to buy physician practices already using ambulatory surgery centers and that its ASC acquisitions were followed by higher prices for competing insurers.Order the February 2026 issue of Health Affairs.Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcast

About this episode: Private insurers and the government typically reimburse providers based on metrics of appointments and procedures. An innovative approach to health care finance asks doctors and clinicians to measure success differently: by tangible health outcomes. In this episode: Dr. Darshak Sanghavi details the early promise of this approach and how it's empowering communities to focus on better health. Guests: Dr. Darshak Sanghavi is a pediatrician, a health care innovator, and a former program manager at the Advanced Research Projects Agency for Health (ARPA-H). Host: Dr. Josh Sharfstein is distinguished professor of the practice in Health Policy and Management, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: Transforming Population Health — ARPA-H's New Program Targeting Broken Incentives—New England Journal of Medicine ARPA-H launches program to reduce preventable deaths—ARPA-H Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients: The Million Hearts Longitudinal ASCVD Risk Assessment Tool—Circulation Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌PublicHealthPod on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

The MAHA backlash over RFK Jr.'s about-face on glyphosate; Amid the partisan divide, Making America Healthy Again cuts across party lines; New study confirms effectiveness of personalized lifestyle interventions for reversing dementia; After an allergic reaction to the Covid shot, is it safe to take other vaccines? Some GLP-1 users are developing scurvy; Six lifestyle hacks that augment weight loss drugs' cardio benefits.

In this week's Healthcare Preview, Debbie Curtis and Rodney Whitlock join Maddie News to discuss how recent world events may affect ongoing congressional and administrative health policy work in 2026.

Health Affairs' Jeff Byers welcomes Brown University's Andrew Ryan to the pod to discuss his recent Forefront article that explores whether value-based payment and managed care can lead to addressing the core drivers of spending.Related Links:Value-Based Payment And Managed Care Will Not Solve The Affordability Crisis (Health Affairs Forefront)“All I Do Is Win”: Why Beating Benchmarks Doesn't Mean That ACOs Are Reducing Costs (Health Affairs Forefront)

Send a textThe wellness industry is booming, but is it actually helping people live better lives? With trillions spent on supplements, special diets, and longevity hacks, it raises a bigger question about what really matters for long-term health.Dr. Zeke Emanuel, Author, Eat Your Ice Cream joins CareTalk to discuss the wellness industrial complex, the health risks of loneliness, and why social connection, simple habits, and even ice cream may matter more than expensive longevity obsessions.

Professor Jeffrey Sachs joins us to talk about his book, To Move the World: JFK's Quest for Peace. Jeffrey Sachs is the Director of The Earth Institute, Quetelet Professor of Sustainable Development, and Professor of Health Policy and Management at Columbia University, and a Research Associate of the National Bureau of Economic Research. He was also Special Advisor to United Nations Secretary General Kofi Annan on a group of poverty alleviation initiatives called the Millennium Development Goals. American Exception followers on Patreon, regardless of the tier, get first access to new episodes! Paid subscribers enjoy access to the entire library of the best historical analysis of deep events on the American Exception podcast.  Subscribe to our Patreon at https://patreon.com/americanexception We are also on youtube at https://www.youtube.com/@americanexception9407 Special thanks to: ·         Dana Chavarria, production ·         Casey Moore, graphics ·         Michelle Boley, animated intro ·         Mock Orange, music

In this episode of The Behavioral View, Nissa Van Etten, Olivia Teal, Elizabeth Barajas, and Yagnesh Vadgama discuss the evolution of outcomes-based care within applied behavior analysis (ABA). Drawing from extensive experience in both clinical practice and payer systems, Vadgama outlines the differences between traditional fee-for-service models and outcomes-based care frameworks. The panel explores how standardized assessments, aggregate data analysis, and empirically supported dosing recommendations can create greater alignment between providers and payers while maintaining individualized clinical decision-making. The discussion addresses administrative burden, prior authorization processes, value-based payment arrangements, caregiver involvement, social determinants of health, and interdisciplinary collaboration. Emphasis is placed on transparency, data-driven decision making, and protecting the integrity of behavior analytic practice while demonstrating measurable outcomes at both the individual and population levels. This course provides practical insight into how outcomes-based care models may shape the future of ABA service delivery. To earn CEUs for listening, click here, log in or sign up, pay the CEU fee, + take the attendance verification quiz to generate your certificate! Don't forget to subscribe and follow and leave us a rating and review. Show Notes:   References  Frazier, T. W., Youngstrom, E. A., Speer, L., Embacher, R., Law, P., Constantino, J., Findling, R. L., Hardan, A. Y., & Eng, C. (2014). Validation of proposed DSM-5 criteria for autism spectrum disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 53(1), 28–40. https://doi.org/10.1016/j.jaac.2013.10.012  Frazier, T. W., Klingemier, E. W., Beukemann, M., Speer, L., Markowitz, L., Parikh, S., & Strauss, M. S. (2021). Development and validation of the Autism Impact Measure (AIM). Journal of Autism and Developmental Disorders, 51, 3407–3421. https://doi.org/10.1007/s10803-020-04795-1  Smith, P. C., Sagan, A., Siciliani, L., & Figueras, J. (2023). Building on value-based health care: Towards a health system perspective. Health Policy, 138, 104918. https://doi.org/10.1016/j.healthpol.2023.104918    AI.Measures Scientific Support   Ferguson, E. F., Frazier, T. W., Hardan, A. Y., & Uljarević, M. (2025). Challenging behavior domains in individuals with neurodevelopmental genetic syndromes: The role of psychological features. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 0(1), 1-12      Frazier, T. W., Huba, K., Frazier, A. R., Womack, R. A., Youngstrom, E. A., Chetcuti, L., Hardan, A. Y., & Uljarevic, M. (2025). Maximizing accurate detection of divergence from normative expectation in behavioral intervention outcome assessment. Research in Autism, 126, 202646.      Frazier, T. W., Youngstrom, E. A., Frazier, A. R., & Uljarevic, M. (2025). A critical appraisal of the measurement of adaptive social communication behaviors in the behavioral intervention context. Behavioral Sciences, 15(6), 722      Frazier, T.W., Helton, M., Akouri, C., Chetcuti, L., Uljarevic, M. (2025) Identifying Reliable Change In Outcome Assessments for Behavioral Intervention. Behavioral Interventions.      Frazier, T. W., Dimitropoulos, A., Abbeduto, L., Armstrong-Brine, M., Kralovic, S., Shih, A., Hardan, A. Y., Youngstrom, E. A., Uljarevic, M., Verbal Beginnings, T. (2024). Psychometric evaluation of the Autism Symptom Dimensions Questionnaire. Developmental Medicine and Child Neurology.      Frazier, T. W., Busch, R. M., Klaas, P., Lachlan, K., Jeste, S., Kolevzon, A., Loth, E., Harris, J., Speer, L., Pepper, T., Anthony, K., Graglia, J. M., Delagrammatikas, C., Bedrosian-Sermone, S., Beekhuyzen, J., Smith-Hicks, C., Sahin, M., Eng, C., Hardan, A. Y., & Uljarevic, M. (2023). Development of informant-report neurobehavioral survey scales for PTEN hamartoma tumor syndrome and related neurodevelopmental genetic syndromes. Am J Med Genet A, 191(7), 1741-1757. https://doi.org/10.1002/ajmg.a.63195      Frazier, T. W., Crowley, E., Shih, A., Vasudevan, V., Karpur, A., Uljarevic, M., & Cai, R. Y. (2022). Associations between executive functioning, challenging behavior, and quality of life in children and adolescents with and without neurodevelopmental conditions. Frontiers in Psychology. https://doi.org/10.3389/fpsyg.2022.1022700      Frazier, T. W., Dimitropoulos, A., Abbeduto, L., Armstrong-Brine, M., Kralovic, S., Shih, A., Hardan, A. Y., Youngstrom, E. A., Uljarevic, M., & Quadrant Biosciences - As You Are Team. (2023). The Autism Symptom Dimensions Questionnaire: Development and psychometric evaluation of a new, open-source measure of autism symptomatology. Developmental Medicine and Child Neurology. https://doi.org/10.1111/dmcn.15497      Frazier, T. W., Dimitropoulos, A., Abbeduto, L., Armstrong-Brine, M., Kralovic, S., Shih, A., Hardan, A. Y., Youngstrom, E. A., Uljarevic, M., Womack, R., Wolf, D., Chappell, N., & Verbal Beginnings Team. (2024). Psychometric Evaluation of the Autism Symptom Dimensions Questionnaire (ASDQ). Developmental Medicine and Child Neurology.      Frazier, T. W., Hyland, A. C., Markowitz, L. A., Speer, L. L., & Diekroger, E. A. (2020). Psychometric evaluation of the revised child and family quality of life questionnaire (CFQL-2). Research in Autism Spectrum Disorders, 70. https://doi.org/https://doi.org/10.1016/j.rasd.2019.101474      Frazier, T. W., Khaliq, I., Scullin, K., Uljarevic, M., Shih, A., & Karpur, A. (2022). Development and psychometric evaluation of the open-source challenging behavior scale. Journal of Autism and Developmental Disabilities. https://doi.org/https://doi.org/10.1007/s10803-022-05750-5      Frazier, T. W., Krishna, J., Klingemier, E., Beukemann, M., Nawabit, R., & Ibrahim, S. (2017). A Randomized, Crossover Trial of a Novel Sound-to-Sleep Mattress Technology in Children with Autism and Sleep Difficulties. J Clin Sleep Med, 13(1), 95-104. https://doi.org/10.5664/jcsm.6398      Frazier, T. W., Busch, R. M., Klass, P., Crowley, E., Lachlan, K., Jeste, S., Kolevzon, A., Loth, E., Harris, J., Pepper, T., Anthony, K., Graglia, J. M., Helde, K., Delagrammatikas, C., Bedrosian-Sermone, S., Smith-Hicks, C., Sahin, M., Eng, C., Hardan, A. Y., . . . Uljarevic, M. (2024). Quantifying Neurobehavioral Profiles across Neurodevelopmental Genetic Syndromes and Idiopathic Neurodevelopmental Disorders. Developmental Medicine and Child Neurology. https://doi.org/https://doi.org/10.1111/dmcn.16112      Uljarevic, M., Cai, R. Y., Hardan, A. Y., & Frazier, T. W. (2022). Development and validation of the Executive Functioning Scale. Front Psychiatry, 13, 1078211. https://doi.org/10.3389/fpsyt.2022.1078211      Uljarevic, M., Spackman, E. K., Cai, R. Y., Paszek, K. J., Hardan, A. Y., & Frazier, T. W. (2022). Daily living skills scale: Development and preliminary validation.   Frazier, T. W., Helton, M., Akouri, C., Chetcuti, L., & Uljarevic, M. (2025). Identifying reliable change in outcome assessments for behavioral interventions. Behavioral Interventions, 40, e70007. https://doi.org/https://doi.org/10.1002/bin.70007    Resources  CentralReach. (n.d.). AI Measures (AIM). https://centralreach.com 

Bruce Chabner is a professor of medicine at Harvard Medical School and clinical director emeritus of the Massachusetts General Hospital Cancer Center. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. I.D. Goldman and B.A. Chabner. Cerebral Folate Deficiency, Autism, and the Role of Leucovorin. N Engl J Med 2026;394:833-835.

Xylitol, FTC Censorship, and the Oral–Heart Health Connection: Nathan Jones, CEO and founder of Xlear, Inc., makers of xylitol-based nasal and dental hygiene products, and a health freedom advocate, discusses Jones' ongoing legal battle with the FTC. He addresses the difficulty of making health claims for hygiene products (including toothpaste and nasal sprays), the role of “weasel words” in supplement marketing, and concerns about regulatory double standards versus pharmaceuticals. He also reviews xylitol's benefits for dental caries and respiratory/ear infections, including references to studies and public-health examples (e.g., Finland and a Belize program reducing dental caries costs), and Jones' efforts to encourage Utah to implement xylitol gum programs in schools. He contrasts fluoride's enamel-strengthening approach with xylitol's effect on the underlying bacterial cause of tooth decay, discusses Utah's fluoride policy change and claims about fluoride's limited benefit, and highlights a correlation between poor oral health and cardiovascular risk via inflammation and bacterial translocation into the bloodstream, including pathogens found in atherosclerotic plaque, and links also discussed for dementia and Parkinson's.  They close with commentary on health advocacy in the “MAHA era,” the challenges of entrenched federal bureaucracy, and Jones' preference for advocacy groups that teach industry to push back rather than comply.

Dr. Hoffman continues his conversation with Nathan Jones, CEO and founder of Xlear, Inc.

Health Affairs' Rob Lott interviews So-Yeon Kang of Georgetown University about her recent paper exploring trends in biopharmaceutical clinical trials after The Inflation Reduction Act of 2022 authorized Medicare to negotiate prices for selected drugs. Order the January 2026 issue of Health Affairs.Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcast

The Roundtable Panel: a daily open discussion of issues in the news and beyond. Today's panelists are public policy and communications expert Theresa Bourgeois, Senior Fellow for Health Policy at The Empire Center for Public Policy Bill Hammond, and Professor in the History Department at John Jay College of Criminal Justice (CUNY) Allison Kavey.

AAF President Douglas Holtz-Eakin, Director of Regulatory Policy Dan Goldbeck, and Director of Health Care Policy Michael Baker join us to discuss the latest on the economy, Trump's regulatory agenda, and health policy. Apple: podcasts.apple.com/us/podcast/the-…st/id1462191777 Spotify: open.spotify.com/show/7aWwYw3EKPmTqLQMbRGR2e

Health Affairs' Jeff Byers welcomes Christina Farr, CEO and editor-in-chief of Second Opinion Media, back to the pod to discuss her book, The Storyteller's Advantage: How Powerful Narratives Make Businesses Thrive. The conversation explores the value of storytelling in the health care and health policy space, how to invest in posting, the catch 22 of "spicy takes," recommendations for the reluctant poster, and Christina shares a quick look into what's interesting in the digital health investment space. 

Sonja Rasmussen is a professor in the Department of Genetic Medicine at Johns Hopkins School of Medicine. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. S.A. Rasmussen and D.B. Jernigan. Antigenic Drift and Antivaccine Shift in the 2025–2026 Influenza Season. N Engl J Med 2026;394:732-735.

In this episode, Joselle sits down with Hannah Preston, a North Carolina social media influencer and public health advocate. They discuss the importance of grassroots digital organizing in driving political change, the intersection of health equity and democracy, and the need for sustained civic engagement beyond election cycles. Hannah shares her journey in public health, the challenges faced during the pandemic, and the role of social media in advocating for health justice.Support the showFollow us on all your favorite platforms! Instagram: @democracyncTikTok: @democracyncThreads: @democracyncBluesky: @democracyncFacebook: @DemocracyNorthCarolinaYoutube: @DemocracyNorthCarolina

Health Affairs' Jeff Byers welcomes Georgetown University's Katie Keith back to the podcast to break down the newly proposed HHS rule that could bring major changes to the ACA beginning in 2027.They discuss the proposal's biggest shifts, including a major push toward expanding catastrophic plans, new marketplace eligibility restrictions tied to the One Big Beautiful Bill Act, and potential impacts on premiums, marketplace enrollment, insurers, and consumers.Related Links:HHS Proposes Sweeping Changes for 2027 Marketplace Plans (Part 1) (Health Affairs Forefront)HHS Proposes Sweeping Changes for 2027 Marketplace Plans (Part 2) (Health Affairs Forefront)Trump Team's Planned ACA Rule Offers Its Answer to Rising Premium Costs: Catastrophic Coverage (KFF Health News)CMS proposes sweeping ACA exchange rule (Healthcare Dive)

In this episode, Krista Drobac, Co Founder of Health Policy Futures Lab, explains how the $50 billion Rural Health Transformation Program is reshaping support for rural hospitals through state led investments in workforce, technology, infrastructure, and new care models. She outlines key program components, timelines, and what hospital leaders should expect as funding and implementation accelerate.

Carmel Shacharis an assistant clinical professor of law and faculty director of the Health Law and Policy Clinic at Harvard Law School. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. H. Howard and C. Shachar. The Rural Health Transformation Program — An Avenue for Promoting Administrative Policies. N Engl J Med 2026;394:625-627.

Health Affairs' Rob Lott interviews John Scott of the University of Washington about his recent paper exploring findings on the financial fallout from traumatic injuries, highlighting persistent medical debt burdens and the policy gaps that leave many patients unprotected. Order the February 2026 issue of Health Affairs.Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcast

About this episode: Products and services like genetic testing, prescriptions for weight loss drugs, and health monitoring wearables are revolutionizing health and wellness in the U.S. But are these new gadgets and offerings easing the challenges facing the health care system or are they exacerbating them? In this episode: Dr. Josh Sharfstein speaks with health care entrepreneur Ashwini Nagappan about the pros and cons of the explosion of direct-to-consumer health care. Guests: Ashwini Nagappan, PhD, is a health care entrepreneur and researcher. Host: Dr. Josh Sharfstein is distinguished professor of the practice in Health Policy and Management, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: How direct-to-consumer health tests could impact insurance, mortgages, and employment—STAT More pharma giants embrace direct-to-consumer sales—Axios A sneak peek of pharma's Super Bowl ads: GLP-1s, tight ends, and more—STAT Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌PublicHealthPod on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

About this episode: Between scratch tickets, casinos, and the recent explosion of sports betting apps, opportunities to gamble abound. So too do opportunities for the development of a gambling disorder—a medical condition as serious as substance use disorders. In this episode: Will Hinman and Christopher Welsh from the Maryland Center of Excellence on Problem Gambling explain how to recognize gambling disorders and where to seek help. Guests: Will Hinman is a certified peer recovery specialist at the Maryland Center of Excellence on Problem Gambling. Dr. Christopher Welsh is an addiction psychiatrist and a professor of psychiatry at the University of Maryland School of Medicine. He is also the medical director of the Maryland Center of Excellence on Problem Gambling. Host: Dr. Josh Sharfstein is distinguished professor of the practice in Health Policy and Management, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: As Online Betting Surges, So Does Risk of Addiction—Hopkins Bloomberg Public Health Magazine New Survey Shows Rising Rates of Disordered Gambling Among Marylanders Since Legalization of Online Sports Betting—University of Maryland School of Medicine Warning Signs—Maryland Center of Excellence on Problem Gambling Voluntary Exclusion Program—Maryland Alliance for Responsible Gaming Public Health and Gambling Part 1: How Gambling Became So Ubiquitous, and the Potential for Problems—Public Health On Call (February 2026) Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌PublicHealthPod on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

About this episode: Sports betting has exploded in popularity, offering bettors the opportunity to gamble on everything from coin tosses to touchdowns. But experts are becoming increasingly concerned about the public health implications. In this episode: Researchers Matthew Eisenberg and Mark Meiselbach discuss the rise of online sports gambling, its potential dangers, and how policy guardrails could make it safer. Guests: Matthew Eisenberg, PhD, is a health economist and associate professor of Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health where he also serves as the Director of the Center for Mental Health and Addiction Policy. Mark Meiselbach, PhD, is a health economist and assistant professor of Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health. Host: Stephanie Desmon, MA, is a former journalist, author, and the director of public relations and communications for the Johns Hopkins Center for Communication Programs. Show links and related content: As Online Betting Surges, So Does Risk of Addiction—Hopkins Bloomberg Public Health Magazine New Survey Shows Rising Rates of Disordered Gambling Among Marylanders Since Legalization of Online Sports Betting—University of Maryland School of Medicine Warning Signs—Maryland Center of Excellence on Problem Gambling Voluntary Exclusion Program—Maryland Alliance for Responsible Gaming Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌PublicHealthPod on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

About this episode: For decades, the recommended immunization schedule has guided physicians through the proper administration of vaccines and empowered individuals to protect themselves against preventable diseases. But recent changes to the schedule and the overhaul of the CDC committee leading vaccine recommendations throws public and personal health into uncharted territory. In this episode: Vaccine expert Walter Orenstein explains the importance of a transparently developed, standardized schedule and shares his concerns about recent changes to the recommendations. Guests: Dr. Walter Orenstein is the associate director of the Emory Vaccine Center. He previously held roles with the CDC and served as the director of the United States Immunization Program and Assistant Surgeon General of the United States Public Health Service. Host: Dr. Josh Sharfstein is distinguished professor of the practice in Health Policy and Management, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: CDC Acts on Presidential Memorandum to Update Childhood Immunization Schedule—U.S. Department of Health and Human Services Who Decides Which Vaccines Americans Should Get and When?—Johns Hopkins Bloomberg School of Public Health The history of the United States Advisory Committee on Immunization Practices (ACIP)—Vaccine Vaccines 101—Public Health On Call Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌PublicHealthPod on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.